drugset / Trial / NCT05994599
Comparative Bioavailability Study of Ethinyl Estradiol/Etonogestrel Vaginal Ring
RandomizedCrossoverSingle-blindPrevention
Summary
Single Dose Crossover Comparative Bioavailability Study of Ethinyl Estradiol/Etonogestrel Vaginal Ring (Delivering 0.015 mg/0.12 mg Per Day) Worn for 21 Days in Healthy Female Subjects
Timeline
- Start
- 2023-07-29
- Primary completion
- 2023-12-11
- Completion
- 2023-12-11
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Etonogestrel | Unknown | 0.12 mg | Other |
| Subject | ethinyl estradiol | Small molecule | 0.015 mg | Other |
Indications
No indication recorded.